Why the study?
Does recombinant human growth hormone alter body composition and regional tissue distributions in adults with growth hormone deficiency?
Does recombinant human growth hormone alter body composition and regional tissue distributions in adults with growth hormone deficiency?
Recombinant human growth hormone treatment in adults with GH deficiency significantly reduces adipose tissue and increases muscle and visceral organ mass, with effects maintained over long-term therapy.
Answers are grounded in this paper and cite their sources.
rhGH favorably alters body composition in GH-deficient adults; confirms compartment-specific effects in this RCT.
This study examines short and long-term effects of recombinant human growth hormone (rhGH) on body composition and regional tissue distributions by using a multicompartment technique based on computed tomography. Part I includes nine subjects aged 46 +/- 9 years with adult onset GH deficiency who were examined before and in the end of 6 months treatment with rhGH (0.4 U.kg-1.week-1) in a double-blind crossover trial. Part II is an ongoing open trial including seven of the males in part I. They were treated with rhGH (0.25 U.kg-1.week-1) over an additional period of 24 months. Adipose tissue (AT) was reduced by 4.7 kg (p < 0.01) while the muscle plus skin compartment (M) and visceral organs (V) were increased by 2.4 (p < 0.05) and 0.7 kg (p < 0.01), respectively, over 6 months of treatment with a high rhGH dose. A preferential lipid mobilization occurred in the visceral and subcutaneous trunk depots resulting in a changed AT distribution. Muscles of legs and arms increased while the increase of trunk muscles did not reach significance. The body composition changes were maintained over 2 years additional treatment. The preferential loss in visceral AT was further pronounced while other changes in tissue distributions observed during the first 6 months tended to be reversed on the lower rhGH dosage. It is concluded that growth hormone has profound and discordant effects on AT, M and V and with associated changes in tissue distributions. The beneficial effects on body composition seen in short-term treatment is preserved throughout an additional 24 months period of treatment.
No takes yet. Share an insight, caveat, or question.
Lönn et al. (1996) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: